Publications
- Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study2024 | Second Faculty of Medicine
- The effect of chemotherapy on cognitive functions in children with leukemia2023 | First Faculty of Medicine, Second Faculty of Medicine
- Recommendations of the Czech Society of Haematology for the diagnosis and treatment of immune thrombocytopenia in adults2023 | Central Library of Charles University
- Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia2022 | Publication without faculty affiliation
- Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study2022 | Publication without faculty affiliation
- Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic Approach2022 | Publication without faculty affiliation
- Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS2022 | Publication without faculty affiliation
- A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS2021 | Second Faculty of Medicine
- Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data2021 | Second Faculty of Medicine
- Experience with TPO agonist treatment in children in view of new guidelines2021 | Publication without faculty affiliation
Loading network view...
